S everal conditions must be present for any bone graft to succeed. The graft site must contain osteogenic cells, in particular osteoblasts, the only cells that directly form bone. Without osteoblasts or the precursor cells from which they form, the process of osteoinduction cannot occur. The graft site must also contain a resorbable scaffold to enable new bone to form by osteoconduction. The grafted scaffold later is resorbed via a cellular-mediated reaction. Soluble regulators, acquired from the blood, adjacent tissue, or from stem cells found in bone marrow, are also essential. The need for their presence at the site is one reason why the establishment of an adequate blood supply is crucial. Achievement of a tension-free closure of the surgical site helps to ensure that the blood supply will be adequate and protects the graft from the oral environment.
An understanding of the mechanisms of bone growth (osteoconduction, osteoinduction, and osteogenesis) can facilitate the selection of the optimal grafting material for any given situation. 1 Available graft materials differ in the mechanisms through which they influence host-bone formation. Freshly harvested autogenous bone brings a rich mixture of osteogenic cells, osteoconductive scaffold material, and soluble regulators to the graft site. 2 For this reason, autografts have long been considered to be the gold standard. However, all autografts require a second surgical site, with the attendant risks of morbidity. To avoid the need to harvest autogenous bone, a variety of biocompatible alternatives have been developed, including allogenic, xenogenic, and alloplastic materials. These materials all provide the graft site with a biocompatible scaffold. None, however, contain live cells. 3 Their success has always depended upon the availability of osteogenic cells and other biologic-regulating agents from the peripheral host bone and blood. 4 -6 
ADULT STEM CELLS
An increased understanding of the nature and role of adult stem cells has introduced the possibility of regenerating bone from allogenic, xenogenic, and alloplastic materials to an extent that approaches or even exceeds the results obtainable with autografts. [7] [8] [9] Stem cells by definition are capable of both self-renewal and differentiation into a variety of mature cell types. Stem cells derived from bone marrow include hematopoietic and mesenchymal stem cells. 10 -13 Transplantation of marrow cells, therefore, gives rise to hematopoietic and osteogenic lineage cells. Hematopoietic stem cells augment the limited number of available stem cells to support angiogenesis and vasculogenesis. Osteoblastic precursors can differentiate into the mature osteoblasts that are needed to promote osteogenesis.
14 Marrow cells promote osteogenesis. Evidence that they contribute to the success of grafts in osseous defects is compelling. [15] [16] [17] Recognizing the potential inherent in combining bone-marrow stem cells with existing allogenic, xenogenic, and alloplastic scaffold materials, the authors have developed a technique for aspirating bone marrow from several sites. 18 Simple and painless, this technique eliminates the need for a second surgical site. Morbidity is minimal.
The focus of this report is an in vivo study of adult stem cells derived utilizing this technique, then mixed with either an allograft, xenograft, or alloplast scaffold. The study objective was to evaluate histologically the extent of new bone growth at such sites.
MATERIALS AND METHODS
Seven graft sites in 5 patients were evaluated. The xenograft scaffold was either PepGen Putty (DENTSPLY Friadent CeraMed, Lakewood, CO) or C-Graft resorbable algae material (Clinician's Preference, Golden, CO). The alloplast scaffold was ␤-tricalcium phosphate (either Curasan AG, Kleinostheim, Germany or Vitoss; Malvern, PA) Three of the patients were grafted using sinus-lift subantral augmentation. 19, 20 The sinus-lift surgery protocol was as follows.
Each patient was prepared and draped, then 2% Xylocaine (CookWaite, Abbot Laboratories, Chicago, IL) with 1:200,000 epinephrine was locally injected. After adequate local anesthesia was achieved, a crestal incision and vertical relief incision were made. A mucoperiosteal flap was reflected along the crestal alveolar bone, superiorly to the height of the vestibule. The flap exposed the region of the canine fossa, malar buttress, and region of the pterygomaxillary fissure and the tuberosity. The procedure continued with the development of a quadrilateral osteotomy. After lifting the sinus membrane, the graft material (either peptide-enhanced anorganic bovine particles, resorbable algaederived material, or ␤-tricalcium phosphate) was mixed with bonemarrow aspirate and inserted. The flap was then repositioned and sutured.
The fourth patient received an onlay particulate graft. For this procedure, a mucoperiosteal flap was reflected exposing the labial cortical bone. Decortication of the labial plate was accomplished. A titanium mesh was secured with screws on the palate. A guided bone regenerative membrane was placed under the mesh, and under the membrane, a loose compaction of bone-marrow aspirate mixed with PepGen P-15 (DENTSPLY Friadent CeraMed) anorganic bovine putty was deposited. The titanium mesh was then secured with screws on the labial, and the periosteum was relieved to obtain primary closure without tension at the incision. The site was sutured with 3-0 Vicryl material (Ethicon, Inc., Johnson & Johnson, Somerville, NJ).
The fifth patient's left maxillary ridge in the canine-bicuspid area was grafted using a tunneling technique. A vertical mucoperiosteal incision was made, and a subperiosteal tunnel was developed. A composite graft consisting of bone-marrow aspirate mixed with loosely compacted C-Graft resorbable material was injected through the tunnel.
In each case, the bone marrow was extracted from the patient using the technique described in detail by Smiler and Soltan. 18 This technique can be performed as an outpatient procedure with the patient under oral sedation and local anesthesia, intravenous sedation, or general anesthesia. The bone marrow can be extracted from the sternum, posterior ilium, or anterior iliac crest. A bone-marrow aspiration needle is held with the index finger near the tip to control the depth of penetration. The needle is then advanced with steady pressure and a twisting motion through the cortical bone to approximately 1 cm inside the marrow cavity. (Decreased resistance indicates penetration into the marrow cavity.) The obturator/stylet is removed, and a 10-mL syringe is attached to the needle. Following aspiration of 2-4 ml of bone marrow, the needle is removed.
All 5 patients were allowed to heal for 4 -7 months. After obtaining informed consent, specimens of the grafted areas were taken with trephine drills. These were then submitted to an oral pathologist for standard histologic and histomorphogenic evaluation.
The analysis measured the percentage of graft material that had been converted into bone, percentage that was unresorbed, and remaining interstitial tissue. In addition, all bone identified in the biopsies was assessed to ascertain the percentage of bone that appeared to be vital.
RESULTS

Case 1
After sinus-lift surgery to create the graft-recipient site, bone-marrow aspirate was mixed with C-Graft resorbable material and deposited with loose compaction to reconstitute the buccal wall of the maxilla. After 4 months, a biopsy was taken with a trephine drill from the crestal bone to the superior aspect of the graft.
The percentage of the biopsy that was found to be bone was 31%. One hundred percent of that bone was vital. The percentage of unresorbed graft material within the core was 26%. Interstitial material constituted the remaining 43%. Within the cancellous bone pattern, all the graft particles were well incorporated. Fig. 1 shows the overall view of the core and reveals the new bone formation bridging the graft particles. Remodeling of mature bone is evident. New bone formation with C-Graft and the pattern of the coral are seen at high power in Fig. 2 .
Case 2
Bilateral sinus-lift surgery was initiated, and the right sinus was loosely filled with pure phase ␤-tricalcium phosphate mixed with bone-marrow aspirate to reconstitute the lateral wall. The left sinus recipient site was grafted with PepGen P-15 anorganic bovine particulate. After 4 months, biopsies were taken with a trephine drill from the crestal bone to the superior aspect of the grafts.
The percentage of the right-sinus (␤-tricalcium phosphate) core biopsy that was found to be bone was 40%. One hundred percent of that bone was vital. The percentage of non-bone within the core was 3%. The remaining 57% of the sample consisted of interstitial material. All the graft particles were well incorporated within the cancellous bone pattern. Fig. 3 shows good bone formation and distribution in the core biopsy. The bone appears to be very dense, with a good cancellous pattern incorporating wellformed trabeculae, connective tissue, and graft material particles. Tricalcium phosphate particles are embedded in the newly formed bone with evidence of osteoid and osteoblasts (Fig. 4) .
The percentage of the left-sinus (PepGen P-15) core biopsy that was found to be bone was 14%, with 100% of that bone found to be vital. The percentage of non-bone within the core was 36%. The tight compaction of the graft material that is evident in Fig. 5 suggests an explanation for the decreased bone formation. Tight compaction of the scaffold leads to a decrease in space between the particles and a decrease in bone formation between the particles. Fig. 6 is a highpower image showing new bone formation with osteoid and osteoblasts and PepGen P-15 interaction with bone. The PepGen P-15 particles are both embedded in and attached to the bone.
Case 3
Bilateral sinus-lift surgery was initiated, and both sinuses were grafted with ␤-tricalcium phosphate (Vitoss) mixed with bone-marrow aspirate. After 4 1/2 months, biopsies were taken with a trephine from the crestal bone to the superior aspect of both grafts. The percentage of the right-sinus biopsy that was found to be bone was 23%, with 89% of that bone found to be vital. The percentage of non-bone within the core was 13%. The percentage of the left-sinus biopsy found to be bone was 16%, with 86% of the bone found to be vital.
New bone formation and resorbing graft matrix within the right biopsy can be seen in Fig. 7 . A high-power image (Fig. 8) shows viable cells within the lacunae of new bone formation in the right biopsy core.
Case 4
This core was taken from the anterior maxilla particulate onlay graft with PepGen P-15 after 4 months of healing. The percentage of the biopsy that was found to be bone was 32%, with 100% of that found to be vital. The percentage of non-bone identified within the core There is significant tight compaction of the P-15 scaffold, leading to a decrease in space between particles and decrease in bone formation. Fig. 6 . Very high-power shows PepGen P-15 particles embedded in bone, and new bone formation with osteoid and osteoblasts. was 15%. The remaining 53% consisted of interstitial material.
The core shows a sound cancellous bone pattern with new-bone formation independent of the particles of PepGen P-15 (Fig. 9) . A few particles are incorporated into the new bone formation. A very high-power image (Fig. 10) shows new bone formation, which is attached to the PepGen P-15 particles.
Case 5
After 7 months of healing, a biopsy core was taken and found to consist of 45% newly formed bone. All of that bone was vital, and there was no residual graft material present. Fig. 11 shows that the cancellous bone pattern is composed of very thick trabeculae. New bone formation with C-Graft and the pattern of the scaffold are seen at high power in Fig. 12 .
DISCUSSION
Bone-graft healing involves the recruitment and proliferation of cells capable of restoring the graft site to its original form and function. Over the years, the success of bone-grafting procedures has only occasionally been evaluated using histomorphometric techniques.
Peleg et al 21 reported on 156 sinus floor augmentations and 37 alveolar ridge grafts. Half the sinus augmentations were grafted with a 50% mix of Bio-Oss (Osteohealth, Shirley, NY) and surface-derived (cortical) autogenous bone. The other half was grafted with autogenous bone alone. The ridge augmentation patients were grafted with cortical autogenous bone. Biopsy cores of the grafts were taken between 4 and 8 months after healing. The core biopsies showed on average immature, newly formed bone and on average 27% to 36% vital bone.
Moy et al 22 reported on a biopsy core taken from a single patient 25 months after sinus grafting with autogenous bone. They described the composition of the core as being 59.4% bone and 40.5% soft tissue.
Pejrone et al 23 reported on histomorphometric results of 6-month biopsy cores from 13 patients grafted with autogenous iliac bone blocks that showed a mean percentage of 54.1 mineralized tissue in the grafts.
Froum et al 24 reported on a core biopsy taken from 1 patient who had had a sinus augmentation with Puros mineralized cancellous bone allograft (Zimmer Dental Inc., Carlsbad, CA) mixed with autogenous bone. After 9 months of healing, the vital bone content was 25.2%, connective tissue and marrow constituted 58%, and 16.8% was residual graft material.
Hans-Dieter and Wenz 25 reported the analysis results from 21 patients whose sinus augmentation was with Bio-Oss natural bone mineral alone and 13 patients grafted with a combination of Bio-Oss and autogenous bone. Biopsies were taken from all patients 3-8 months after surgery. Histomorphometric analysis showed no statistically significant difference between the patients grafted with only Bio-Oss (overall amount of 29.52% new bone formation) and the Bio-Oss/ autogenous bone group (overall amount 32.23% new bone formation).
In a comparative analysis of sinus augmentation with different biomaterials, Scarano et al 26 reported on the results of 94 patients. Each patient un- derwent biopsy after 6 months of healing. A total of 144 biopsies were retrieved. Those who had been grafted with autogenous bone showed an average of 40.1% newly formed bone, with residual graft particles averaging 18%. Those who received demineralized freeze-dried bone had an average of 29% newly formed bone, with 34% residual graft. Those who got PepGen P-15 had an average of 37% new bone, with 37% residual particles. Those grafted with Bio-Oss had an average of 39% new bone, with 31% residual particles.
Schopper et al 27 reported histomorphologic findings of 26 patients 6 months after bone augmentation with Algipore (same as C-Graft; DENTSPLY Friadent, Mannheim, Germany) in 1999. Histological examination revealed a physiologic framework of cancellous bone formed around Algipore biomaterial particles. The mean percentage of mineralized bone was 20.3%.
Szabo et al 28 in 2005 reported the results of using Cerasorb (␤-tricalcium phosphate; Curasan AG) versus autogenous bone for bilateral sinus grafts of 20 patients. Analysis of biopsies taken at 6 months showed the mean percentage of bone for the Cerasorb to be 36.47%. The mean percentage for the autogenous bone was 38.34%. The difference between the 2 results was not statistically significant.
It is important to note that of the recent studies, only 2 studies 21,24 reported on what percentage of the total new bone was vital bone. That percentage ranged from 25.2% to 36%. All the other studies identified the percentage of mineralized bone or new bone formation but failed to distinguish the percentage of active living cells contained within the newly formed bone. In contrast, the current study identifies the percentage of viable bone. In 5 of the 7 sites biopsied, 100% of the bone was vital (containing living cells), while in the other 2 sites, the respective percentages were 89% and 86%.
In the 1 case where only 14% of the biopsy core contained mineralized bone, overcompaction of the grafting site was evident, an error that likely contributed to the limited success of the graft. In case No. 3, where Vitoss TCP was the graft material, the low percentages of new bone within the core (16% for the left sinus and 23% for the right sinus) might be explained by the physical properties of the graft scaffold. Vitoss granules have a porosity of about 90%. In contrast, Cerasorb granules have a porosity of 65%, making them more stable. The interconnecting pore distribution of Cerasorb is also narrower than that of the Vitoss particles. Furthermore, Cerasorb granules are pure-phase, while Vitoss granules have a foreign phase proportion of approximately 2%.
Another potential cause of variation in the results obtained when using stem cells may be the age of the patient. As patients age, their red marrow (rich in stem cells) decreases and is replaced by yellow marrow (poor in stem cells). Techniques for concentrating the stem cells for older patients are now being evaluated.
In 4 of the 7 cases included in the current study, the percentage of mineralized bone identified (between 31% and 45%) compares favorably with the mean percentage of mineralized bone found by Szabo et al 28 (38.34%) in sites grafted with autogenous bone. Furthermore, the use of stem cells aspirated from bone marrow eliminates the need for the creation of a second surgical site for harvesting autogenous bone.
Additional studies are needed to investigate how stem cells influence the development and repair of peripheral tissue. Markers for stem cells of different tissues and organs are currently under study.
CONCLUSIONS
Although preliminary in nature and limited in scope, this study demonstrates that the combination of stem cells (derived from bone marrow) with a scaffold material within a bonegrafting site can produce a significant quantity of viable bone. The therapeutic potential of bone regeneration by such cell-based strategies is highly promising.
14 Stem cells derived from bone marrow are remarkably plastic and pluripotent, and they can roam throughout the body, taking up residence wherever they are needed to promote regeneration.
15,16
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The authors are on the board of directors of the not-for-profit Platinum Foundation for Research and Education, which sponsored this research and manuscript. Curasan (Cerasorb) has made a financial contribution to the foundation. The authors claim not to have a financial interest in Curasan, or a financial interest in any company whose products are mentioned in this article. net Un análisis histomorfogénico de injertos de hueso aumentados con células troncales adultas ABSTRACTO: Propósito: Evaluar la influencia de la aspiración de la médula de hueso agregada al andamiaje de la matriz del heteroinjerto o aloplasto para producir hueso. Materiales y métodos: Un máximo de 4 cc de médula de hueso se aspiró de la cresta ilíaca anterior de cinco pacientes para saturar el andamiaje de la matriz antes del injerto de hueso. Los siete lugares del injerto evaluados incluyeron el aumento del seno, injerto de partículas "onlay" del maxilar a través del procedimiento de túnel, e injerto de partículas "onlay" del maxilar estabilizado con una malla de titanio. El andamiaje del heteroinjerto fue PepGen Putty (Dentsply, Friadent CeraMed, Lakewood, Colorado) o material de alga reabsorbible C-Graft (Clinician's Preference, Golden, Colorado). El andamiaje del aloplasto fue ␤-fosfato tricálcico (Curasan AG, Kleinostheim, Alemania o Vitoss, Malvern, Pennsylvania). Resultados: Los lugares del injerto se curaron durante cuatro a siete meses. Se tomaron muestras del núcleo del lugar del injerto con brocas trefinas y las mismas fueron presentadas para análisis histológico e histomorfogénico normal. Se midieron el porcentaje del material del injerto convertido a hueso, el porcentaje de la matriz vital del injerto, el porcentaje de matriz no reabsorbida, y el porcentaje del tejido intersticial restante. Luego de cuatro meses de curación del aumento del seno con C-Graft, la biopsia demostró un 31% de hueso que era un 100% vital. El material del injerto no reabsorbido era un 26% y el material intersticial restante constituyó un 43%. Usando ␤-fosfato tricálcico de fase pura, una biopsia del núcleo principal a los cuatro meses demostró un 40% del hueso que era un 100% vital. El injerto residual fue un 3% y el material intersticial un 57%. Un seno injertado con PepGen P-15 demostró tener un 14% de hueso, con un 100% categorizado como hueso vital. La parte que no era hueso dentro del núcleo era 36%. Después de 4 meses y medio de curación de los injertos bilaterales del seno usando ␤-fosfato tricálcico que no era de fase pura, el porcentaje de la biopsia que era hueso fue un 23% en el costado derecho y un 16% en el costado izquierdo. El hueso vital fue del 89% (costado derecho) y un 86% (lado izquierdo). El núcleo tomado después de 4 meses de curación del injerto "onlay" con partículas en el maxilar anterior con PepGen P-15 demostró un 32% de hueso, con un 100% como vital. La parte que no era hueso dentro del núcleo era un 15% y un 53% fue material intersticial. Después de siete meses de curación el núcleo de la biopsia de la cresta maxilar aumentada con C-Graft fue un 45% de hueso recientemente formado, con un 100% como hueso vital. No hubo material residual del injerto. Discusión: La regeneració n del hueso a través de estrategias basadas en células depende de un entendimiento de la biología y potencial de las células troncales adultas como una manera de regenerar el hueso. Conclusión: La aspiración de médula de hueso que contiene células troncales adultas cuando se mezclan con materiales de injerto de bioingeniería proporciona un andamiaje para apoyar la proliferació n, diferenciació n y maduració n de las células troncales así como facilitar la angionesis. Este artículo presenta evidencia histoló gica de que las células troncales aspiradas de la médula de hueso y trasplantadas en andamiajes biocompatibles pueden exitosamente regenerar el hueso. Esta nueva norma para el injerto de hueso podría emerger como una alternativa a los injertos autól-ogos de hueso. Avaliar a influência do aspirado de medula óssea adicionado ao suporte da matriz de xenoenxerto ou enxerto aloplástico para produzir osso. Materiais e méto-dos: Um máximo de 4cc's de medula óssea foi aspirado da crista ilíaca anterior de cinco pacientes para saturar o suporte da matriz antes do enxerto ósseo. Sete locais de enxerto avaliados incluíram aumento da cavidade, enxerto "onlay" particulado da maxila via procedimento de tunelização e enxerto "onlay" particulado da maxila estabilizado com malha de titânio. O suporte do xenoenxerto era PepGen Putty (Dentsply, Friadent CeraMed, Lakewood, Colorado) ou material de algas reabsorvíveis C-Graft (Clinician's Preference, Golden, Colorado). O suporte aloplástico era fosfato ␤-tricálcio (Curasan AG, Kleinostheim, Germany ou Vitoss, Malvern, Pennsylvania). Resultados: Os locais de enxerto ficaram curados de quatro a sete meses. Espécimes nucleares de locais de enxerto foram tiradas com broca trefina e submetidas a análise histológica e histomorfogênica padrão. A porcentagem de material de enxerto convertido em osso, a porcentagem de matriz de enxerto vital, a porcentagem de matriz não-reabsorvida e a porcentagem de tecido intersticial remanescente foram medidas. Após quatro meses de cura do aumento da cavidade com C-Graft, a biópsia mostrou 31% de osso que era 100% vital. O material de enxerto não-reabsorvido era 26% e o material intersticial remanescente constituía 43%. Usando fosfato ␤-tricálcio de fase pura, uma cópia nuclear de após quatro meses mostrou 40% de osso que era 100% vital. O enxerto residual foi 3% e o material intersticial, 57%. Observou-se que uma cavidade enxertada PepGen P-15 era 14% osso, com 100% daquele osso vital. O não-osso dentro do núcleo era 36%. Após 4 1 ⁄2 meses de cura de enxertos de cavidades bilaterais usando fosfato ␤-tricálcio de fase não-pura, a porcentagem da biópsia que era osso foi 23% no lado direito e 16% no lado esquerdo. O osso vital era 89% (lado direito) e 86% (lado esquerdo). O núcleo tirado após 4 meses de cura do enxerto "onlay" particulado da maxila anterior com PepGen P-15 mostrou 32% de osso com 100% constatado como sendo vital. O não-osso dentro do núcleo era 15% e 53% era material intersticial. Após sete meses de cura, um núcleo de biópsia do rebordo maxilar aumentado com C-Graft era 45% osso recém-formado com 100% de osso. Não havia material de enxerto residual presente. Discussão: A regeneração do osso por meio de estraté-gias baseadas em células depende de uma compreensão da biologia e potencial de células-tronco adultas como meio de regenerar tecido. Conclusão: O aspirado de medula óssea contendo células-tronco adultas quando misturado como materiais de enxerto bio-usinados fornece um suporte para sustentar a proliferação, diferenciação e maturação das células-tronco, bem como facilita a angiogênese. Este artigo apresenta evidência histológica de que as células-tronco aspiradas da medula óssea e transplantadas para suportes biocompatíveis podem regenerar osso com sucesso. Este novo padrão para enxerto ósseo pode emergir como alternativa para enxertos ósseos autógenos. 
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